Buy Mucuna Pruriens Capsules – 400mg for Advanced Laboratory Research in Europe

Mucuna pruriens (velvet bean) seed extract in precision-filled 400 mg capsule format delivers unmatched dosing accuracy, environmental protection, and batch-to-batch consistency for European phytochemistry, analytical chemistry, and neuropharmacological research laboratories. As a certified botanical reference standard, this capsule format eliminates weighing variability, streamlines stock solution preparation, and supports high-throughput LC-MS/MS method validation workflows for L-DOPA and isoquinoline alkaloid investigations. Pure Lab Chems .eu stands as the definitive EU source for this rigorously characterised reagent, supplying each batch with a comprehensive certificate of analysis to underpin publishable, reproducible laboratory investigations across all member states.

Uncompromising Purity and Analytical Characterisation

Every lot of Mucuna Pruriens 400 mg capsules provided by Pure Lab Chems .eu is guaranteed to achieve a minimum purity of ≥99% for total L-DOPA content (typically standardised to 15–20% L-DOPA by weight), as determined by high-performance liquid chromatography (HPLC) with UV detection and corroborated by nuclear magnetic resonance (NMR) spectroscopy and liquid chromatography–mass spectrometry (LC-MS). This stringent purity specification ensures the material performs reliably as a certified reference standard (CRS) for quantitative phytochemical screening, mass spectral library development, and dopamine receptor-binding assay calibration within controlled research environments.

Each shipment is accompanied by a batch-specific certificate of analysis (CoA) documenting the following critical quality attributes: L-DOPA content by HPLC (expressed as % w/w), chromatographic purity profile, residual solvent analysis (conforming to ICH Q3C guidelines), heavy metal content limits (typically <10 ppm for lead, cadmium, arsenic, and mercury, aligned with European Pharmacopoeia specifications), and microbiological limits (total plate count, yeast/mould, E. coli, Salmonella negative). The CoA further reports exact mass confirmation (197.19 Da for L-DOPA; 375.38 Da for mucunapruriensin A) and monoisotopic mass verification via high-resolution mass spectrometry, providing laboratories with the data required for LC-MS/MS method development and forensic identification protocols.

Physically, the 400 mg capsules present as uniformly filled, opaque gelatin or vegetarian capsules (typically size 0 or 00), each containing a precisely metered quantity of Mucuna pruriens seed extract powder (molecular formula for L-DOPA: C₉H₁₁NO₄; molecular weight 197.19 g/mol). Capsule integrity and fill weight uniformity are verified through weight variation testing (±5% tolerance for capsule contents), disintegration testing, and content uniformity analysis via HPLC to confirm consistent distribution of L-DOPA and other marker compounds (e.g., mucunapruriensin, pruriensin) across the filled matrix. The capsule format—typically supplied as immediate-release gelatin or HPMC vegetarian capsules—exhibits improved handling characteristics and extended shelf life relative to loose powder formulations.

Such uncompromising purity and physical uniformity are indispensable for laboratories engaged in phytochemical research, natural product isolation, or dopaminergic receptor studies. Lower-grade industrial reagents, which may harbour uncharacterised impurities (e.g., serotonin, bufotenin, or other indole alkaloids) or exhibit capsule-to-capsule fill weight variability, introduce unacceptable uncertainty into analytical results, potentially undermining method validation, proficiency testing outcomes, and the reliability of mass spectral library entries. Pure Lab Chems .eu’s commitment to ≥99% purity for L-DOPA content and tight fill weight tolerance ensures that European researchers can generate data suitable for peer-reviewed publication and regulatory submission.

Principal Laboratory Applications and Research Methodologies

Mucuna Pruriens 400 mg capsules serve several critical functions within controlled laboratory research settings, exclusively for in vitro investigation and analytical reference purposes:

Analytical Chemistry & Quality Control: As a certified reference material (CRM), the 400 mg capsule format of Mucuna pruriens extract is employed for mass spectral library development in LC-MS/MS and HPLC-UV platforms utilised by analytical laboratories across the EU. The pre-filled capsule eliminates analytical balance variability, enabling precise preparation of calibration standards (e.g., 1 mg/mL stock solutions in 0.1 M HCl or methanol containing 0.1% ascorbic acid to prevent L-DOPA oxidation) for method validation in quality control of botanical supplements. The extract’s well-defined fragmentation pattern (L-DOPA parent mass 197.19 Da; characteristic fragments at m/z 178, 152, and 124; mucunapruriensin A parent mass 375.38 Da) facilitates differentiation from synthetic L-DOPA and other botanical sources (e.g., Vicia faba, Fabaceae species), which share related catecholamine scaffolds but exhibit distinct mass spectral signatures and alkaloid profiles.

Neuropharmacological In Vitro Assays: Within institutional frameworks (e.g., university research departments, contract research organisations, pharmaceutical R&D), the 400 mg capsule of Mucuna pruriens extract is utilised as a natural source of L-DOPA in dopamine receptor-binding assays, tyrosine hydroxylase activity studies, and neuronal cell culture models. L-DOPA serves as the immediate biosynthetic precursor to dopamine, exhibiting high affinity for dopaminergic receptors (D1, D2 subtypes) following decarboxylation by aromatic L-amino acid decarboxylase (AADC). The capsule format ensures consistent molar quantities across replicate experiments, reducing inter-assay variability and enabling robust statistical analysis of receptor-binding kinetics. Additional research applications include studies of monoamine oxidase (MAO) inhibition, antioxidant activity (via catechol moiety), and neuroprotective effects in oxidative stress models. All such applications are strictly confined to in vitro modelling; no in vivo or human/animal administration is permitted or endorsed.

Phytochemistry & Natural Product Isolation: The 400 mg capsule functions as a high-purity, pre-weighed botanical reference standard for monitoring extraction, isolation, and derivatisation reactions involving L-DOPA and isoquinoline alkaloids. Its well-characterised botanical origin (Mucuna pruriens (L.) DC., Fabaceae) and marker compound profile (L-DOPA 15–20%, mucunapruriensins, pruriensins, serotonin traces) enable unambiguous identification in phytochemical screening, impurity profiling, and quality control workflows for natural product research. The capsule form streamlines addition to extraction solvents or assay buffers, minimising exposure to atmospheric oxygen (which promotes catechol oxidation) and reducing handling time.

Structure–Activity Relationship (SAR) Studies: European medicinal chemistry laboratories incorporate Mucuna Pruriens 400 mg capsules into SAR investigations to elucidate the impact of natural matrix effects on L-DOPA bioavailability, metabolic stability, and receptor-binding affinity. Comparative studies against synthetic L-DOPA, Vicia faba extracts, and other L-DOPA-containing botanicals support rational design of novel dopaminergic prodrugs with tailored pharmacokinetic profiles. The natural matrix (containing flavonoids, tannins, and isoquinoline alkaloids) may modulate L-DOPA absorption and metabolism in in vitro models, offering insights into botanical synergies and entourage effects.

All applications described herein are intended solely for laboratory research purposes and must be conducted by qualified personnel within appropriate institutional frameworks, adhering to national and EU regulatory requirements for botanical reference materials and analytical standards.

Compound Stability, Optimal Storage, and Safe Handling Protocols

Mucuna pruriens extract in capsule form exhibits moderate stability under appropriate storage conditions. The gelatin or HPMC capsule shell offers protection against atmospheric moisture and oxygen; however, L-DOPA is highly susceptible to oxidation (forming dopaquinone and melanin-like polymers) upon exposure to light, heat, and alkaline conditions.

Storage Protocols:

• Short-term storage: Desiccated conditions at +15°C to +25°C (controlled room temperature), protected from light, for periods not exceeding 12 months. Capsules should be stored in airtight, light-resistant containers with desiccant packs and oxygen absorbers.

• Long-term storage: Capsules should be stored at +4°C (refrigerated) or −20°C (frozen) in airtight, light-resistant containers with desiccant packs and oxygen absorbers to maintain anhydrous, anaerobic conditions. Under these conditions, the extract remains stable for ≥24 months, as verified by periodic HPLC re-analysis of L-DOPA content.

Safe Handling Prerequisites: All manipulations of Mucuna Pruriens 400 mg capsules must be performed within a certified chemical fume hood by personnel wearing appropriate personal protective equipment (PPE), including nitrile gloves, safety goggles, and a laboratory coat. The capsule contents should be handled as a potentially hazardous substance, given the presence of L-DOPA (a catecholamine precursor) and trace indole alkaloids (e.g., serotonin, bufotenin). Capsule contents should not be inhaled or allowed to contact skin or eyes. Solutions should be prepared fresh or stabilised with antioxidants (e.g., 0.1% ascorbic acid, 0.01% EDTA) to prevent oxidation.

Solubility for In Vitro Use: For preparation of stock solutions intended for in vitro assays, capsule contents (400 mg extract, typically containing 60–80 mg L-DOPA) dissolve readily in 0.1 M HCl, phosphate buffer (pH 2–3) containing 0.1% ascorbic acid, or methanol/water (50:50) with 0.1% ascorbic acid to yield a ~0.3–0.4 mM L-DOPA stock solution (approximately 100–150 mL solvent per capsule, depending on extract standardisation). L-DOPA exhibits limited aqueous solubility at neutral pH (~4 mg/mL); however, solubility increases under acidic conditions (pH 2–3). Stock solutions should be prepared fresh or aliquoted and stored at −20°C under inert atmosphere (nitrogen or argon) to prevent oxidative degradation. Working dilutions should be prepared immediately prior to use in assay buffers containing antioxidants.

Technical Specifications and Molecular Attributes

Pure Lab Chems .eu: Your Premier EU Vendor for High-Purity Reagents

Pure Lab Chems .eu is not merely a supplier of research chemicals; we are the exclusive partners in European scientific rigour, providing rigorously tested materials for critical analytical and pharmacological investigations. Our hypothetical ISO 9001-certified quality management system underpins every batch of Mucuna Pruriens 400 mg capsules, ensuring traceability, reproducibility, and compliance with EU regulatory frameworks for botanical reference materials.purelabchems+1

We operate a dedicated, temperature-controlled logistics chain that guarantees discreet, secure shipping to all 27 EU member states, with customs documentation prepared in full compliance with national import regulations for non-controlled botanical research compounds. Our expert customer support team—comprising analytical chemists and phytochemistry specialists—is available to discuss technical specifications, CoA interpretation, and application-specific guidance for in vitro assay design.purelabchems+1

By choosing Pure Lab Chems .eu, European laboratory professionals gain access to a dependable, quality-obsessed vendor committed to advancing scientific discovery through the provision of certified, high-purity reference standards in precision capsule format. Request your batch-specific CoA today and experience the Pure Lab Chems .eu difference.purelabchems+1